Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Yuhan's sales revenue distribution 2018, by sector

Distribution of sales revenue of Yuhan Co., Ltd. in 2018, by business sector

by Won So, last edited Mar 19, 2019
Yuhan's sales revenue distribution 2018, by sector This statistic presents the distribution of sales revenue of the South Korean pharmaceutical company Yuhan Co, Ltd. in 2018, broken down by business sector. In 2018, the sales revenue of prescription (ethical-the-counter, ETC) drugs accounted for around 67.5 percent of the company's annual sales revenue.
Show more

Distribution of sales revenue of Yuhan Co., Ltd. in 2018, by business sector

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.